Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/21/2012CN102791724A Carbon monoxide releasing rhenium compounds for medical use
11/21/2012CN102791719A Crystal of diamine derivative and method of producing same
11/21/2012CN102791718A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
11/21/2012CN102791717A Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012CN102791716A 2,5,7-substituted oxazolopyrimidine derivatives
11/21/2012CN102791715A Tricyclic compounds for use as kinase inhibitors
11/21/2012CN102791714A N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as PDE10A inhibitors
11/21/2012CN102791713A Imidazo [1,2-A] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
11/21/2012CN102791712A Pyrazolopyrimidine derivative
11/21/2012CN102791711A 1, 7-diazacarbazoles and their use in the treatment of cancer
11/21/2012CN102791710A 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
11/21/2012CN102791709A Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
11/21/2012CN102791708A Inhibitors of akt activity
11/21/2012CN102791705A Inverse agonists and neutral antagonists for the TSH receptor
11/21/2012CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
11/21/2012CN102791703A Pyrazines as delta opioid receptor modulators
11/21/2012CN102791702A Prodrugs of [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof
11/21/2012CN102791701A 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase IV(DPP-IV) inhibitors
11/21/2012CN102791700A Process for the preparation of a polymorph of strontium ranelate
11/21/2012CN102791699A Fumagillol type compounds and methods of making and using same
11/21/2012CN102791698A 2-phenyl-1,2,3-benzotriazoles for UV radiation absorbance
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791696A Amino alcohol derivatives and their therapeutic activities
11/21/2012CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators
11/21/2012CN102791693A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
11/21/2012CN102791690A Di-substituted pyridine derivatives as anticancers
11/21/2012CN102791689A 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin D2 receptor modulators
11/21/2012CN102791688A Estrogen receptor ligands
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102791307A Removal of virulence factors through extracorporeal therapy
11/21/2012CN102791282A Orally administerable pharmaceutical preparation containing insulin
11/21/2012CN102791278A Cell protectants comprising placenta extracts
11/21/2012CN102791274A Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
11/21/2012CN102791273A Small pyrimidine derivatives and methods of use thereof
11/21/2012CN102791272A Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
11/21/2012CN102791271A Method for improving dissolvability of anticoagulant
11/21/2012CN102791270A Methods and compositions for applying moxifloxacin to the ear
11/21/2012CN102791269A PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
11/21/2012CN102791268A Treating critically ill patients with intravenous ibuprofen
11/21/2012CN102791267A Anti-inflammatory analgesic adhesive patch for external use
11/21/2012CN102791266A Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
11/21/2012CN102791265A Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation
11/21/2012CN102791264A Oil and fat composition for prevention or treatment of diabetes
11/21/2012CN102791263A Combination composition, comprising as active ingredient L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
11/21/2012CN102791262A D-amino acids for use in treating biofilms
11/21/2012CN102791261A Compounds for the treatment of renal cell carcinoma
11/21/2012CN102791260A Uses of hypoxia-inducible factor inhibitors
11/21/2012CN102791258A Extended release formulations of rasagiline and uses thereof
11/21/2012CN102791256A Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
11/21/2012CN102791150A Coffee treatment method
11/21/2012CN102791134A Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
11/21/2012CN102791130A Treatment of lupus nephritis using laquinimod
11/21/2012CN102791127A Compositions, methods, and devices for the treatment of dysmenorrhea
11/21/2012CN102787158A Method for producing natural beta-carotene by fermentation and application
11/21/2012CN102786687A Polyasparaginyl-L-cysteine and polyasparaginyl-L-methionine with polymerization degree of 59, preparation method and application thereof
11/21/2012CN102786576A Triptolide derivatives, and preparation methods, medicinal composition and uses thereof
11/21/2012CN102786575A Diosgenin-3-derivative as well preparation method and application thereof
11/21/2012CN102786574A Glycyrrhetinic acid crystal A substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786573A Glycyrrhetinic acid crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786572A Ribavirin crystal C characterization and preparation methods, and applications of Ribavirin crystal C in medicines and healthcare products
11/21/2012CN102786571A Ribavirin crystal D, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786570A Macrolide compounds, preparation method thereof, application thereof and intermediate thereof
11/21/2012CN102786562A Pyrrolizidine alkaloids and purpose thereof
11/21/2012CN102786549A Tenofovir diester compounds with activity of inhibiting HIV-1 (human immunodeficiency virus-1) virus replication and preparation method and pharmaceutical use thereof
11/21/2012CN102786538A Salicylaldehyde glycine Schiff base and o-phenanthroline copper (II) coordination compound and preparation process and application thereof
11/21/2012CN102786535A Polymerization aaptamine alkaloid compounds, preparation method thereof and application of polymerization aaptamine alkaloid compounds
11/21/2012CN102786529A Pterocarpan compound and preparation process and application thereof
11/21/2012CN102786525A N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof
11/21/2012CN102786522A Matrine derivative, its preparation method and application
11/21/2012CN102786521A Risperidone crystal III substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786520A Praziquantel crystal A substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786519A Praziquantel crystal B substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786518A Palmatine hydrochloride crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786517A Pyrimidine thiazole amine derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102786515A 2-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-group)morpholine and preparation method and application
11/21/2012CN102786513A Omeprazole crystal E substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786509A 2-(5,6-methylxanthone-4-yl)-acetic acid derivatives, preparation method and uses thereof
11/21/2012CN102786493A 2,3-diaryl thiazolidinone compound and analogue, and purpose thereof in preparing antiangiogenic drugs
11/21/2012CN102786484A Tetramethylpyrazine formyloxy cinnamic acid derivative and preparation method and application thereof
11/21/2012CN102786483A Medicinal use of 4-(4-phenylpiperazino)quinazoline derivatives
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786476A Novel compounds as opioid receptor modulators
11/21/2012CN102786469A O-pyridylhydrazide derivatives, and preparation method, medicinal composition and uses thereof
11/21/2012CN102786468A Nicotinic acid derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102786464A Ftibamzone derivative and preparation method and application thereof
11/21/2012CN102786462A Arbidol hydrochloride crystal B, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786461A Arbidol hydrochloride crystal E, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786458A Pyrrole formamide derivative, and preparation method and application thereof
11/21/2012CN102786447A N,N-disubstituted aryl sulfonamide compound as well as preparation method and purpose of N,N-disubstituted aryl sulfonamide compound
11/21/2012CN102786434A Acetaminophen acid derivative, preparation method and application thereof
11/21/2012CN102786433A Rhizoma corydalis amide compound extract, preparation method and application
11/21/2012CN102786418A Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products
11/21/2012CN102786417A Chlorogenic acid crystal III characterization and preparation methods, and applications of chlorogenic acid crystal III in medicines and healthcare products
11/21/2012CN102786414A Compound for treating and/or preventing neurodegenerative related disease
11/21/2012CN102786402A 1-(2-hydroxyl-4-isoamylene oxy)-phenyl-3-substituted phenyl-2-propylene-1-ketone derivative used for antidepressant drugs
11/21/2012CN102786401A Phenylpolyene compounds and their preparation method and use
11/21/2012CN102786394A Substituent bis-aryl methylene naphthenic base derivative as well as preparation method and application thereof
11/21/2012CN102784600A Preparation method of lutein microcapsule
11/21/2012CN102784398A Composition comprising endostatin adopted as delivery system and chemically-synthesized RNA interference molecule, and application thereof
1 ... 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 ... 7860